Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has submitted copies of newspaper publications of its Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025 (Q1 FY26) to the stock exchanges. The results were approved by the Board on August 14, 2025 and were published in Business Standard (English) and Desh Sewak (Punjabi) on August 15, 2025. The filing is made under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, which mandates newspaper publication of quarterly financial results. The detailed extract of results is also available on the company's website and the stock exchange websites.
This is a routine procedural compliance filing with no new financial information beyond what was already disclosed when the Q1 results were approved on August 14, 2025. No material impact on shareholders or stock price is expected from this filing alone.